To respond to ABA research protocol deviations adverse events unanticipated problems and noncompliance, protect immediate safety and ordinary care, preserve the facts, and notify the protocol's responsible investigator. Classify the event under the approved protocol and governing institutional rules, track each reporting clock, and involve the IRB or other authority as required. Correct causes, communicate new risks, protect enrolled participants, and document validated closure without silently rewriting the record.

Define Gideon's governed activity and unit

Research incident response begins with safety and factual preservation, then follows the event-specific protocol, authority, clock, and participant-protection route. Teams using this guide need the exact activity, people, purpose, design, data, site, sponsor, funding, institutional scope, authority, current version, participant protections, and unresolved facts before work begins.

Build Gideon's research incident and deviation log

Gideon records event ID, detection time, participant and study, protocol version, actual sequence, planned sequence, immediate safety action, ordinary clinical care, injury or distress, privacy or data impact, expectedness, relationship to participation, new risk, deviation type, possible noncompliance, reporter, investigator notification, IRB and institutional route, sponsor or funder route, legal and insurer clocks, containment, affected cohort, consent update, enrollment hold, amendment, root causes, corrective action, participant communication, evidence, owner, deadlines, and closure. Allegations and confirmed findings remain distinct states.

Protect participants and ordinary care in Gideon's workflow

Gideon's seventeen protocol departures, adverse events, data incidents, and compliance concerns must preserve client dignity, ordinary clinical access, voluntary choice, privacy, communication and AAC, authorized decision-making, safety response, equitable treatment, complaints, and freedom from retaliation. A research label, consent signature, payment, supervisor approval, or publication goal cannot expand a role or erase a required protection.

Work through Gideon's fictional example

Gideon locks 17 event records. Fourteen have complete initial classification, required notifications, participant protection, and due-date evidence. Three remain open because relatedness, affected-record scope, or the institution's reporting determination is pending. All immediate safety actions proceed while classification continues. Preserve every proposed, classified, reviewed, approved, exempted, enrolled, changed, reported, published, corrected, held, withdrawn, and closed state with its original version, owner, date, conditions, and validation.

Use Gideon's denominator carefully

Initial response completeness is 14 of 17, or 82.4%. Open records remain in the cohort. Deviations, adverse events, unanticipated problems, noncompliance findings, participants, notifications, and corrective actions are different units and should not be pooled.

Assign Gideon's decisions to authorized owners

Gideon coordinates documentation. Investigators and qualified clinicians address research and clinical risks within scope. The IRB and institution make determinations assigned to them. Privacy, safety, legal, sponsor, funder, licensing, insurer, and data owners handle their routes without waiting for another route to finish.

Address Gideon's main interpretation risk

An adverse event is not automatically an unanticipated problem, and a deviation can increase risk without injury. Premature labels can overreport, underreport, or distract from immediate protection.

Verify Gideon's research control in practice

Gideon reconstructs sampled events from source records and timestamps, then checks the exact protocol and institutional rule in effect. Reviewers confirm that every required recipient received the right information and that corrections work in practice.

Place Gideon's project inside organizational accountability

Gideon's research incident and deviation log uses the CASP Organizational Guidelines public overview only for high-level business, clinical-operations, and risk-management scope in autism service organizations. CASP sells the detailed guidelines. The workflow here is Finni's editorial governance model, not a CASP research protocol, regulatory determination, or institutional approval.

Apply the BACB research duties to Gideon's covered roles

Gideon's role review uses the current BACB Ethics Code, which applies to BCBA and BCaBA certificants and people who completed an application. Its research section addresses applicable review, participant welfare, informed consent, confidentiality, competence, conflicts, integrity, authorship, publication, and corrections. BACB has no separate organization or corporation jurisdiction, so institutional and legal controls remain necessary.

Anchor Gideon's federal scope to the current HHS rule

Gideon's federal analysis starts with the HHS 45 CFR 46 page, reviewed in February 2025, which identifies the 2018 Requirements and added subparts for specified populations. Applicability depends on funding, conduct, assurance, institution, activity, and other facts. The page is an authoritative starting point, while the current rule and responsible institution control the determination.

Use the OHRP decision charts as aids for Gideon

Gideon's reviewer may use the OHRP 2018 Requirements decision charts to organize research, human-subject, exemption, continuing-review, and consent-waiver questions. OHRP calls the charts generalizations and directs users to the full applicable text. They support intake and discussion; they do not authorize an investigator to self-approve a project.

Classify quality improvement carefully for Gideon

Gideon's project label follows the OHRP Quality Improvement Activities FAQs. OHRP explains that intent to publish is insufficient to decide whether QI is research and that some QI can be nonexempt human-subjects research. Purpose, design, activity, coverage, and an authorized determination matter more than the label chosen by the project team.

Separate HIPAA research permission for Gideon

Gideon's privacy review uses HHS research guidance under HIPAA, which explains that covered entities may use or disclose PHI for research with individual authorization or through limited rule-defined paths without authorization. Common Rule consent, IRB action, HIPAA authorization or waiver, data-owner approval, and contract terms remain separate decisions even when one document combines information.

Treat informed consent as a process for Gideon

Gideon's communication plan draws on the OHRP Informed Consent FAQs. OHRP flags that the FAQ predates the 2018 Requirements and 2024 conforming changes, while retaining general nonbinding guidance. Use the current regulation and review decision. The FAQ describes prospective, legally effective, voluntary information exchange with questions and a real choice to join, continue, or withdraw.

Apply child-research requirements precisely for Gideon

Gideon's child-participant route uses current 45 CFR 46 Subpart D, amended in October 2024. The IRB determines adequate provisions for parental or guardian permission and for child assent when the child is capable, subject to the rule's conditions and possible waivers. Clinical assent policies and research assent determinations should be recorded separately.

Distinguish adverse events and unanticipated problems for Gideon

Gideon's incident logic uses OHRP guidance on unanticipated problems and adverse events. The guidance explains that only a subset of adverse events are unanticipated problems and describes unexpectedness, relation or possible relation, and increased risk as the three-part analysis. Use the current protocol, institution, and rules for actual reporting decisions and deadlines.

Scope research-misconduct handling for Gideon

Gideon's integrity route recognizes the 2024 final rule revising 42 CFR Part 93. The rule became effective January 1, 2025, and its regulatory requirements apply beginning January 1, 2026, to covered Public Health Service research-misconduct matters. Allegations received before that applicability date generally follow the 2005 rule unless the institution and respondent elect the new rule in writing. The current rule addresses fabrication, falsification, and plagiarism and excludes honest error or differences of opinion. Other sponsors, institutions, journals, employers, and laws can use different processes; preserve allegations as allegations until the authorized process decides them.

Make Gideon's participation process accessible

Gideon's access plan uses DOJ effective-communication guidance for covered title II or title III entities. The appropriate aid or service depends on the interaction's nature, length, complexity, context, and the person's usual communication method. Apply the actual entity and rule, preserve AAC and authorship, and test consent, recruitment, questions, incident notices, and withdrawal routes in the formats participants use.

Choose Gideon's next review trigger

Review after new facts, recurring deviation, delayed report, changed relatedness, increased frequency, participant complaint, protocol amendment, consent update, suspension, or failed corrective action. Record the changed fact, affected people and records, immediate protection, governing source, decision owner, reporting or amendment route, deadlines, communication, and validation result.

Close Gideon's record with accountable evidence

Review the research incident and deviation log with Gideon, investigators, qualified clinicians, the institution or reviewing body, participant representatives as applicable, and the specialists named in the manifest. Confirm that service, QI, evaluation, research, review, consent, privacy, safety, data, employment, authorship, publication, and misconduct routes remain distinct; all conditions are traceable; access is tested; and unresolved work has an accountable endpoint. Keep this page draft and noindex until every required review is complete.

Related resources

Sources